The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 27, 2024

Filed:

Feb. 22, 2021
Applicant:

Aortic Innovations, Llc, Hillsboro Beach, FL (US);

Inventors:

Ali Shahriari, Hillsboro Beach, FL (US);

Justin R. Nifong, Lexington, NC (US);

Assignee:

Aortic Innovations, LLC, Hillsboro Beach, FL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61F 2/24 (2006.01); A61F 2/07 (2013.01); A61F 2/90 (2013.01); A61F 2/958 (2013.01); A61F 2/962 (2013.01); A61F 2/06 (2013.01);
U.S. Cl.
CPC ...
A61F 2/2418 (2013.01); A61F 2/07 (2013.01); A61F 2/2433 (2013.01); A61F 2/90 (2013.01); A61F 2/958 (2013.01); A61F 2/962 (2013.01); A61F 2002/061 (2013.01); A61F 2002/075 (2013.01); A61F 2/2412 (2013.01); A61F 2210/0076 (2013.01); A61F 2220/005 (2013.01); A61F 2250/0015 (2013.01); A61F 2250/0023 (2013.01); A61F 2250/0039 (2013.01); A61F 2250/0051 (2013.01); A61F 2250/006 (2013.01); A61F 2250/0069 (2013.01);
Abstract

A transcatheter valve assembly includes a main body that defines a braided stent frame having a proximal end and a distal end and a graft material covering at least a portion of the braided stent frame. The graft material is coupled to the braided stent frame at each of the proximal end and the distal end. The braided stent frame is configured to modify a length and diameter thereof to fit a diameter of a patient. A medial portion defines one of an open facing surface that is positioned proximal the coronary arteries when the valve assembly is deployed, and a pair of conduits configured for receiving a stent to fluidly engage with the coronary arteries when the valve assembly is deployed. A valve housing is at the proximal end of the transcatheter valve assembly.


Find Patent Forward Citations

Loading…